During the past decade, Herzzentrum Lahr conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Herzzentrum Lahr" #1 sponsor was "CVRx, Inc." with 2 trials, followed by "Pfizer" with 2 trials sponsored, "Cogentus Pharmaceuticals" with 1 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored and "Deutsches Herzzentrum Muenchen" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Herzzentrum Lahr" #1 collaborator was "Amgen" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "BMBf (Federal Ministry of Education and Research)" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator and "Chiltern International Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Herzzentrum Lahr" are "Coronary Artery Disease" (3 trials), "Cardiovascular Disease" (2 trials), "Acute Coronary Syndrome" (1 trials), "Atrial Fibrillation" (1 trials) and "Heart Failure" (1 trials). Many other conditions were trialed in "Herzzentrum Lahr" in a lesser frequency.

Most popular intervention types in "Herzzentrum Lahr" are "Drug" (5 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "bococizumab (PF-04950615)" (2 trials), "BAROSTIM NEO™ System" (1 trials), "Barostim Neo™ System" (1 trials) and "CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Herzzentrum Lahr" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Herzzentrum Lahr". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Herzzentrum Lahr, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Herzzentrum Lahr, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".